Interferon alpha 1/13 (IFNA1, IFNA13) is synthesized by macrophages and possesses antiviral activities. It is an acid-stable molecule that signals through IFNα/βR, which is also utilized by IFNβ. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase. IFNA1 is the most abundantly expressed IFNA subtype and primarily originates from plasmacytoid dendritic cells (pDC), which are the earliest cells recruited to the sites of virus entry. Individual IFNA subtypes have been found to exhibit distinct efficacies in terms of viral protection, with IFNA1 demonstrating low potency, as determined by both antiviral and antiproliferative activities. The role of IFN-alpha in the development of autoimmune diabetes can either be suppressive or promotive, suggesting a complex involvement in the etiology of type 1 diabetes.
Product name | hIFNA1(24-189)-His |
Species | Homo sapiens |
Expression system | HEK293 |
Buffer | PBS, pH 7.4 |
Delivery condition | Dry ice (-80°C) |
Delivery Time | 1 week if in stock; 4 weeks if production needed |
Storage condition | Store at -80°C |
Brand | BioMetas |
Applications | AIDS/HIV, Allergy Research, Angiogenesis/Cardiovascular Research, Cancer Research, Immune Checkpoint, Immune System, Immunotherapy, Targeted Therapy |
Aliases/Synonyms | IFNa1, IFN-alpha 1, IFN alpha-1, IFNA13, IFNa13, IFNA, IFL, IFN-alphaD, LeIF D |
Reference | |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Size | 1mg, 5mg, 10mg, 50mg, 100mg |
Brand | BioMetas |
Product type | Cytokine |
Expression system | HEK293 |
Applications | AIDS/HIV, Allergy Research, Angiogenesis/Cardiovascular Research, Cancer Research, Immune Checkpoint, Immune System, Immunotherapy, Targeted Therapy |
Fig. 1.) 4-20% SDS-PAGE analysis
Recombinant protein was visualized by Coomassie Brilliant Blue R250 staining.
Fig. 2.) SEC-HPLC analysis
Column: Superdex 200 Increase 5/150 GL
Running buffer: 2xPBS, pH 7.4